Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. 1994

R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
Clinical Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md.

OBJECTIVE To determine the impact of treatment on scholastic performance in the first cohort of survivors of childhood acute lymphoblastic leukemia who are old enough to have completed their educational experience. METHODS Retrospective cohort study. METHODS Twenty-three institutions in the Childrens Cancer Group. METHODS A total of 593 adult survivors of childhood acute lymphoblastic leukemia and 409 sibling controls. METHODS Enrollment in special programs, grades during high school, graduation from high school, college admission, and college graduation. RESULTS After diagnosis, survivors were more likely than their sibling controls to enter a special education (relative risk [RR] = 3.4; P < .01) or a learning disabled (RR = 3.6; P < .01) program, while just as likely to enter gifted and talented programs (RR = 1.0). The risk associated with special education and learning disabled programs increased with increasing dose of cranial radiotherapy. Despite these problems, survivors generally had the same probability as their siblings of finishing high school, entering college, and earning a bachelor's degree. However, survivors treated with 24 Gy and those diagnosed before 6 years of age were less likely to enter college (RR = 0.67 and 0.6, respectively; P < .01). CONCLUSIONS This large study demonstrates that childhood acute lymphoblastic leukemia survivors have a greater likelihood of being placed in special education or learning disabled programs than their siblings, but that most are able to overcome these problems. Dose of cranial radiotherapy and age at diagnosis are the most important education-related risk factors.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004519 Education, Special Education of the individual who markedly deviates intellectually, physically, socially, or emotionally from those considered to be normal, thus requiring special instruction. Special Education,Educations, Special,Special Educations
D004522 Educational Status Educational attainment or level of education of an individual. Education Level,Educational Achievement,Educational Attainment,Educational Level,Level of Education,Maternal Education Level,Maternal Educational Attainment,Maternal Educational Level,Paternal Education Level,Paternal Educational Attainment,Paternal Educational Level,Achievement, Educational,Educational Status, Maternal,Educational Status, Paternal,Maternal Educational Status,Paternal Educational Status,Status, Educational,Attainment, Educational,Attainment, Maternal Educational,Attainment, Paternal Educational,Education Level, Maternal,Education Level, Paternal,Education Levels,Educational Achievements,Educational Attainment, Maternal,Educational Attainment, Paternal,Educational Attainments,Educational Level, Maternal,Educational Level, Paternal,Educational Levels,Level, Education,Level, Educational,Level, Maternal Education,Level, Maternal Educational,Level, Paternal Education,Level, Paternal Educational,Levels, Maternal Educational,Maternal Education Levels,Maternal Educational Attainments,Maternal Educational Levels,Paternal Education Levels,Paternal Educational Attainments,Paternal Educational Levels,Status, Maternal Educational,Status, Paternal Educational
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
July 2008, Pediatric blood & cancer,
R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
October 2009, Hematology/oncology clinics of North America,
R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
December 1985, Italian journal of neurological sciences,
R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
August 2014, Pediatric blood & cancer,
R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
October 1982, Cancer research,
R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
August 1986, Cancer,
R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
November 2003, The New England journal of medicine,
R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
July 2016, Cancer,
R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
June 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R Haupt, and T R Fears, and L L Robison, and J L Mills, and H S Nicholson, and L K Zeltzer, and A T Meadows, and J Byrne
June 2003, Medical and pediatric oncology,
Copied contents to your clipboard!